With 0.18 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.18 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.81 whereas the lowest price it dropped to was $1.73. The 52-week range on EPIX shows that it touched its highest point at $7.88 and its lowest point at $1.40 during that stretch. It currently has a 1-year price target of $2.00. Beta for the stock currently stands at 1.60.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of EPIX was up-trending over the past week, with a rise of 17.76%, but this was up by 11.87% over a month. Three-month performance surged to 2.29% while six-month performance fell -69.92%. A look at the trailing 12-month EPS for EPIX yields -0.70 with Next year EPS estimates of -0.49. For the next quarter, that number is -0.19. This implies an EPS growth rate of -10.94% for this year and 30.99% for next year. EPS is expected to grow by 8.52% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 15.68%.
Float and Shares Shorts:
At present, 44.39 million EPIX shares are outstanding with a float of 41.72 million shares on hand for trading. On 2025-03-31, short shares totaled 0.63 million, which was 143.0 higher than short shares on 1740700800. In addition to Dr. David Ross Parkinson M.D. as the firm’s President, CEO & Director, Mr. David S. Wood C.M.A., CPA, CMA, CPA, M.B.A., MBA serves as its Chief Financial Officer.
Institutional Ownership:
Through their ownership of 0.72128 of EPIX’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-12-31, EPIX reported revenue of $0.0 and operating income of -$9917430.0. The EBITDA in the recently reported quarter was -$11279515.0 and diluted EPS was -$0.19.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With EPIX analysts setting a high price target of 1.70807 and a low target of 1.70807, the average target price over the next 12 months is 1.70807. Based on these targets, EPIX could drop -4.58% to reach the target high and fall by -4.58% to reach the target low. Reaching the average price target will result in a decline of -4.58% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.63926 being high and -$0.72643 being low. For EPIX, this leads to a yearly average estimate of -$0.678. Based on analyst estimates, the high estimate for the next quarter is -$0.24 and the low estimate is -$0.24. The average estimate for the next quarter is thus -$0.24.
